Spring direct naar de hoofdnavigatie of de inhoud
‘The best results are obtained when there is an exchange of creative thinking between the patent attorney and the client. I truly enjoy achieving and maintaining such synergy.’
Annemiek Tepper

Annemiek Tepper

  • Chemistry
  • Life Sciences
  • European and Dutch Patent Attorney, European Patent Litigator
  • Partner

Annemiek Tepper joined V.O. in 2002. During her academic career, she spent one year at the University of Chapel Hill (USA) and at the Pasteur Institute in Paris. Annemiek studied biochemistry at the University of Groningen. She obtained her PhD at the Netherlands Cancer Institute (Amsterdam).

Continue reading

Her specialties include biochemistry, biotechnology, oncology, immunology, diagnostics, medical technology, dairy science and food technology. She is actively involved in assessing the patentability of new developments, and in drafting and prosecuting patent applications worldwide. Other activities include evaluating third party patent portfolios and providing opinions of validity/invalidity and infringement/non infringement. She is also experienced in representing clients in opposition and appeal cases before the EPO. Her clients are diverse and range from academic institutions, SME’s to multinationals.

In her capacity as European Patent Litigator, Annemiek is allowed to act as UPC representative.

Working experience

  • Patent Attorney, V.O. (2006-present)
  • Post-Doc, Academic Medical Center (2000-2002)

Education

  • PhD, Faculty of Science, University of Amsterdam (2000, with honours)
  • MSc in Biochemistry, University of Groningen (1994, with honours)

Directories

  • Highlighted as ‘exceptional attorney’ by IP Stars Handbook MIP, 2016.

Publications

  • Tepper AD, Ruurs P, Borst J, van Blitterswijk WJ (2001) Biochim. Biophys. Res. Commun. 280:634
  • Tepper AD, Diks SH, van Blitterswijk WJ, Borst J (2000) J. Biol. Chem. 275:34810
  • Tepper AD, Ruurs P, Wiedmer T, Sims PJ, Borst J, van Blitterswijk WJ (2000) J. Cell Biol. 150:155
  • Tepper AD and van Blitterswijk WJ (2000) Methods Enzymol. 312:16
  • Tepper AD, de Vries E, van Blitterswijk WJ, Borst J (1999) J. Clin. Invest. 103:971
  • Tepper AD, Boesen-de Cock JG, de Vries E, Borst J, van Blitterswijk WJ (1999) J. Biol. Chem. 272:24308
  • Boesen-de Cock JG, Tepper AD, de Vries E, van Blitterswijk WJ, Borst J (1999) J.Biol. Chem. 274:14255
  • Borst P, van Blitterswijk WJ, Borst J, Tepper AD, Schinkel AH (1998) Drug Resistance Update 1:337
  • Boesen-de Cock JG, Tepper AD, de Vries E, van Blitterswijk WJ, Borst J (1998) J. Biol. Chem. 273:7560
  • Tepper AD, Dammann H, Bominaar AA, Véron M (1994) J. Biol. Chem. 269:32175
  • Véron M, Tepper A, Hildebrandt M, Lascu I, Lacombe ML, Janin J, Moréra S, Cherfils J, Dumas C, Chiadmi M (1994) Adv. Exp. Med. Biol. 370:607
  • Bominaar AA, Tepper AD, Véron M (1994) FEBS Lett. 353(1):5

Professional & Community Activities

  • Member of the Committee ‘professional orientation’ of the Dutch Patent Association (Orde van Octrooigemachtigden) aimed to promote the profession of patent attorney
  • EPI Tutor

Languages

  • English
  • Dutch

Also see these experts

Sara Calitz

Sara Calitz

  • European Patent Attorney
  • Associate
More experts

News

Trade secrets: the importance of discretion

Annelies de Bosch Kemper-de Hilster, Head of Legal at V.O., explains why trade secrets play an important role within organizations.Continue reading

T 873/24 and the reach of G 1/24 claim interpretation in added-matter analysis (Board of Appeal 3.3.05) 

In T 873/24 (Board of Appeal 3.3.05, oral proceedings 3 February 2026), the Board indicated that it would refer questions to the Enlarged Board of Appeal (EBA) on whether (and how) the Enlarged Board’s claim-interpretation guidance in G 1/24 extends to the assessment of added subject-matter under Article 123(2) EPC (and, by implication, Article 76(1) […]Continue reading

Düsseldorf Local Division adopts The Hague’s four-step test for infringement by equivalence and applies a structured “feature-by-feature function” analysis 

In its decision in Wonderland v Cybex (UPC_CFI_807/2024 and UPC_CFI_334/2025, Local Division Düsseldorf, 27 May 2026), the Düsseldorf panel addressed — in detail — the assessment of patent infringement by equivalent means under Art. 69 EPC and the Protocol.Continue reading

Events

BIO International Convention 2026

San Diego Convention Center, Harbor Drive, San Diego, San Diego, CA, USA

BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with over 20,000 industry leaders from across the globe.

Continue reading